1. DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
   Marzena Ciechomska et al, 2019, Cells CrossRef
2. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
   Mohamed H. Yousef et al, 2020, BioMed Research International CrossRef
3. Fraxetin Inhibits the Proliferation and Metastasis of Glioma Cells by Inactivating JAK2/STAT3 Signaling.
   Liangchen Qu et al, 2021, Evid Based Complement Alternat Med CrossRef
4. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
   Chunhong Hu et al, 2021, Clin Epigenet CrossRef
5. Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
   Wenjing Xiao et al, 2021, Front. Pharmacol. CrossRef
6. Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
   Pooja Yadav et al, 2021, CDT CrossRef
7. 5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer
   Marion Turpin et al, 2022, Front. Mol. Biosci. CrossRef
8. Recent advances in epigenetic anticancer therapeutics and future perspectives
   Liwen Ren et al, 2023, Front. Genet. CrossRef
9. Nanoparticles loaded with the DNA methyltransferase inhibitor SGI-1027 decrease murine atherosclerosis and inflammation in cultured human macrophages
   Ana Cristina Márquez-Sánchez et al, 2024, Explor Cardiol CrossRef
10. null
    Fabiola E. Tristan-Flores et al, 2024 CrossRef
11. Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application
    Lin Su et al, 2024, Clinical & Translational Med CrossRef